The Cost of Not Breastfeeding: Global Results From A New Tool
The Cost of Not Breastfeeding: Global Results From A New Tool
The Cost of Not Breastfeeding: Global Results From A New Tool
doi: 10.1093/heapol/czz050
Advance Access Publication Date: 24 June 2019
Original Article
Abstract
Evidence shows that breastfeeding has many health, human capital and future economic benefits
for young children, their mothers and countries. The new Cost of Not Breastfeeding tool, based on
open access data, was developed to help policy-makers and advocates have information on the
estimated human and economic costs of not breastfeeding at the country, regional and global lev-
els. The results of the analysis using the tool show that 595 379 childhood deaths (6 to 59 months)
from diarrhoea and pneumonia each year can be attributed to not breastfeeding according to
global recommendations from WHO and UNICEF. It also estimates that 974 956 cases of childhood
obesity can be attributed to not breastfeeding according to recommendations each year. For
women, breastfeeding is estimated to have the potential to prevent 98 243 deaths from breast and
ovarian cancers as well as type II diabetes each year. This level of avoidable morbidity and mortal-
ity translates into global health system treatment costs of US$1.1 billion annually. The economic
losses of premature child and women’s mortality are estimated to equal US$53.7 billion in future
lost earnings each year. The largest component of economic losses, however, is the cognitive
losses, which are estimated to equal US$285.4 billion annually. Aggregating these costs, the total
global economic losses are estimated to be US$341.3 billion, or 0.70% of global gross national
income. While the aim of the tool is to capture the majority of the costs, the estimates are likely to
be conservative since economic costs of increased household caregiving time (mainly borne by
women), and treatment costs related to other diseases attributable to not breastfeeding according
to recommendations are not included in the analysis. This study illustrates the substantial costs
of not breastfeeding, and potential economic benefits that could be generated by government and
development partners’ investments in scaling up effective breastfeeding promotion and support
strategies.
Introduction 2016). For these reasons, the World Health Organization (WHO)
Newborns and young children receive essential benefits through and UNICEF recommend early initiation of breastfeeding within an
breastfeeding resulting in improved survival, health and human cap- hour of birth, exclusive breastfeeding of infants for the first 6
ital outcomes. Breastfeeding reduces the risk of childhood infections months of life and continued breastfeeding with complementary
such as diarrhoea and pneumonia and premature mortality as well foods for two or more years (UNICEF, 2016a).
as minimizes nutrition-related harm to cognitive development in Despite the substantial evidence on the health and cognitive
early childhood (Horta et al., 2015; Victora et al., 2016). For breast- benefits of breastfeeding, the vast majority of children globally are
feeding mothers, breastfeeding reduces the risk of post-partum not breastfed in line with the recommendations. The global preva-
haemorrhage and depression as well as premature mortality from lence of exclusive breastfeeding increased from 36% in 2000 to
several diseases later in life (Chowdhury et al., 2015; Victora et al., 43% in 2015, and the current prevalence of early initiation of
C The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
V
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. 407
408 Health Policy and Planning, 2019, Vol. 34, No. 6
Key Messages
• The new Cost of Not Breastfeeding Tool is a first-of-its-kind resource to help policy-makers and advocates quantify the
human and economic costs of not breastfeeding including lost life, lost productivity, and increased costs to health sys-
tems at country, regional and global levels.
• Globally, 595 379 childhood deaths are attributed to not breastfeeding annually. Optimal breastfeeding also has the po-
tential to prevent an additional 98 243 deaths of mothers from cancers and type II diabetes each year.
• The total annual global economic losses are estimated to be between US$257 billion and US$341 billion, or between
0.37% and 0.70% of global gross national income.
• The costs of not breastfeeding are significant and should compel policy-makers and donors to invest in scaling up
breastfeeding and nutrition interventions for children and their mothers to strengthen human capital development and
economic outcomes around the world.
breastfeeding according to recommendations, including (1) women’s estimates (Victora et al., 2016). This calculation is based on the fact
and child morbidity and mortality, (2) for health system and house- that lifetime duration of breastfeeding a child reduces the relative
hold formula costs and (3) the future economic costs due to mortal- risk of morbidity from cancer and it is assumed that the effect on
ity and cognitive losses. This study was based on the framework for mortality is of the same magnitude. The number of potential cases
estimating economic costs of not breastfeeding from the Rollins averted with full breastfeeding rates (100%) was calculated by mul-
et al. (2016) Lancet Series on Breastfeeding, which focused on cogni- tiplying the incidence of type II diabetes in women (Institute for
tive losses and healthcare treatment costs for children. While this Health Metrics and Evaluation, 2017) by published relative risk of
analysis was conducted from the societal perspective with certain type II diabetes (Victora et al., 2016) and the current level of breast-
costs borne by households, ministries of health and the economy as feeding in each country. Data on breast and ovarian cancer mortal-
a whole included, the tool design focused on the key costs with ity in women by country are from GLOBOCAN 2012
available data for the majority of countries rather than the exhaust- (International Agency for Research on Cancer, 2012). The tool does
ive inclusion of all type of costs. The estimates are likely to be con- not include the attributed morbidity and mortality consequences
servative since the economic costs of increased household caregiving from childhood diabetes and cancer, sudden infant death syndrome,
time, which are mainly borne by women (Leslie, 1989), transporta- and necrotizing enterocolitis. All regional and country income group
tion costs, and several child and maternal diseases that can be pre- estimates of morbidity and mortality are based on the cumulative
vented in part by breastfeeding are not included in the model due to totals from countries with available data and are not extrapolated to
the data availability. Each indicator was estimated for a 1-year co- fit the total population of the respective group.
hort of newborns and infants not being breastfed according to rec-
ommendations or their mothers. The future economic costs of
Health system and household formula costs
mortality and cognitive losses for this 1-year cohort of child–mother
The health system cost refers specifically to the direct medical costs
pairs, however, are projected into the long-term future over their
for the treatment of cases of childhood diarrhoea and pneumonia
productive years.
(Bagriansky and Voladet, 2013; Bagriansky, 2014; Walters et al.,
2016) and cases of type II diabetes in women that can be attributed
Child and maternal morbidity and mortality to not breastfeeding. The number of cases of each childhood disease
The estimation of the human cost of not breastfeeding follows the attributed to not breastfeeding was multiplied by the percentage of
same methodology from previous studies on the cost of malnutrition children with the disease taken to a health facility, the percentage of
and not breastfeeding (Bagriansky and Voladet, 2013; Bagriansky, cases taken to a health facility that receive either outpatient care
2014; Walters et al., 2016). To estimate the number of childhood services or inpatient services (Lamberti et al., 2012; Niederman and
cases and child deaths averted each year attributable to not breast- Krilov, 2013) and the percentage of patients that seek care at each
feeding according to recommendation, published relative risks for level of care (health centre, primary hospital, secondary hospital or
either the diarrhoea or pneumonia infection pathway (Black et al., teaching/tertiary hospital) in each country. The annual total cost of
2008) were multiplied by the current percentage of households in treatment of diarrhoea and pneumonia attributed to not breastfeed-
each breastfeeding behaviour category, and then multiplied by the ing is equal to the number of cases that receive outpatient and in-
morbidity or mortality for each disease for infants and young chil- patient services at each level of care multiplied by the unit cost of
dren (age 0–23 months). The method used for estimating the mor- treatment for children at each level of care.
bidity and mortality of breast and ovarian cancer and type II The default country-level unit cost data used for the estimation
diabetes attributed with not breastfeeding follows previous of the treatment of childhood diseases was from the WHO-
approaches used in the UK (Pokhrel et al., 2014) and for global CHOICE data (Johns et al., 2005), which were adjusted for the
410 Health Policy and Planning, 2019, Vol. 34, No. 6
cumulative inflation based on country-specific data from 2008 to breastfeeding below 6 months of age compared with non-exclusive
2017 in US dollars (World Bank, 2016). These unit costs pertain breastfeeding can achieve the same cognitive gains equal to a 2.62
crudely to the mean cost of general outpatient services per visit and IQ increase compared with not being breastfed (Horta et al., 2015;
inpatient care per day. Additional data on the unit costs of treatment Victora et al., 2016). The 2.62 IQ increase point estimate was
for childhood diarrhoea and pneumonia were collected from China, adjusted for maternal IQ and used in the tool in order to be conser-
Ethiopia, Ghana, Mexico and Nigeria by UNICEF and Alive & vative (Horta et al., 2015). This approach was supported by evi-
Thrive country teams, consultants and partners, either from national dence from a study that found that children exclusively breastfed for
administrative databases or directly from health facilities (see greater than 1 month experienced an increase in three IQ points
Supplementary Appendix Table A1). compared with children not or partially breastfed for less than 1
The estimated health system cost of treatment for type II diabetes month (Eickmann et al., 2007). Although there is only limited re-
in women is calculated by multiplying the number of annual cases of search on the direct effects of exclusive breastfeeding due to chal-
type II diabetes attributed to not breastfeeding by an estimate on the lenges with feasibility, the approach aligns with UNICEF and WHO
percentage of cases of type II diabetes that are diagnosed. This figure guidelines and data in the infant and young child database
represents the number of cases that are diagnosed and potentially (UNICEF, 2016a; UNICEF, 2017).
Table 1 Number of annual cases of morbidity in women and children attributable to not breastfeeding by region and country income group
Regions Child diarrhoea Child ARI/ Childhood Breast cancer Ovarian Cancer Type II
(0–23 months) pneumonia (0–23) obesity in mothers in mothers diabetes
East Asia and Pacific 19 533 482 1 058 553 374 405 54 393 9 905 389 006
Europe and Central Asia 3 514 920 357 835 69 231 11 016 3 214 52 077
Middle East and 12 704 537 716 047 168 568 8379 902 101 441
North Africa
Latin America and 13 160 409 778 792 134 192 18 254 3 355 118 363
Caribbean
North America 33 571 64 739 0 0 0 0
South Asia 56 056 468 3 346 020 74 249 14 051 2435 121 620
Sub-Saharan Africa 60 843 179 2 317 553 154 311 11 711 1745 75 009
High income 335 534 86 075 9362 3249 728 15 719
Table 2 Number of annual deaths of women and children attributable to not breastfeeding by region and country income group
Regions Due to child Due to child Total child Due to breast Due to ovarian Due to Type II Total number
diarrhoea ARI/pneumonia deaths cancer in cancer in diabetes in of maternal
(0–23 months) (0–23) mothers mothers mothers deaths
East Asia and Pacific 13 932 39 680 53 613 11 898 5922 19 964 37 785
Europe and Central Asia 2132 5302 7434 3007 1877 2683 7567
Middle East and 6455 15 272 21 727 1801 606 5261 7668
North Africa
Latin America and 3938 10 897 14 835 4292 2092 11 503 17 887
Caribbean
North America 0 0 0 0 0 0 0
South Asia 66 530 96 350 162 880 3444 1677 10 791 15 913
Sub-Saharan Africa 132 828 202 064 334 892 2626 1471 8028 12 125
High income 11 95 106 704 471 654 1829
Upper-middle-income 10 928 33 952 44 879 15 677 7619 29 414 52 711
Lower-middle-income 147 999 233 025 381 024 9313 4763 25 323 39 399
Low income 66 877 102 493 169 370 1374 791 2839 5004
Total 225 815 369 565 595 379 27 069 13 644 58 230 98 943
in East Asia and the Pacific region and 54% in upper middle-income estimated to be US$1.1 billion annually (Table 3). The treatment
countries (Table 1), both groupings with rapid growth in commercial costs for childhood pneumonia alone equal US$697 million each
milk-based formula sales in recent years (Baker et al., 2016). year, and childhood diarrhoea and women’s type II diabetes are esti-
mated to cost US$196 million and US$254 million, respectively. For
all three diseases, East Asia and the Pacific would incur the highest
Mother’s morbidity and mortality
cost of any region with a total of US$315 million per year. The
Breastfeeding was estimated to have the potential to prevent 27 069
upper middle-income group of countries would incur the highest
future deaths of women from breast cancer and 13 644 from ovarian
health system cost at US$604 million per year. Supplementary
cancer each year with universal breastfeeding (Table 2). Also,
Appendix Table A3 shows the total annual health system treatment
breastfeeding could potentially prevent 58 230 deaths of women
cost from not breastfeeding according to recommendation for >138
from type II diabetes. In contrast with child mortality, the majority
individual countries with data available.
of preventable maternal deaths due to not breastfeeding, 53% occur
The online search for e-commerce vendors in all countries found
in upper middle-income countries and 38% occur in the East Asia
data on infant formula in 97 countries (Supplementary Appendix
and the Pacific region alone (Table 2). Results for the maternal and
Table A2). The global mean price per 900-g container of the lowest
child morbidity and mortality indicators from 130 individual coun-
Table 3 Total health system cost attributed to not breastfeeding by region and country income group
Regions Due to childhood Due to childhood Due to type II diabetes Total (US$ m)
diarrhoea (US$ m) pneumonia (US$ m) morbidity in mothers’ (US$ m)
Table 4 Global and regional economic losses due to mortality, cognitive losses and total attributable to not breastfeeding by region and by
country income group
Due to child Due to maternal Due to cognitive Total cost Total cost as
mortality (US$ b) mortality (US$ b) losses (US$ b) (health, mortality % of GNI
and cognitive) (US$ b)
East Asia and Pacific 10.39 (2.71, 49.67) 0.66 (0.55, 0.80) 74.76 (19.46, 357.66) 86.12 (23.04, 408.45) 0.59 (0.16, 2.78)
Europe and Central Asia 1.35 (0.35, 6.38) 0.25 (0.21, 0.29) 14.76 (3.86, 70.15) 16.27 (4.37, 76.71) 0.42 (0.11, 1.97)
Middle East and North Africa 3.76 (0.98, 17.99) 0.03 (0.03, 0.04) 18.65 (4.85, 89.38) 22.57 (5.98, 107.54) 0.91 (0.24, 4.32)
Latin America and Caribbean 4.08 (1.07, 19.35) 0.28 (0.23, 0.34) 32.25 (8.41, 154.02) 36.85 (9.94, 173.95) 0.70 (0.19, 3.32)
North America 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 114.94 (29.87, 551.37) 114.97 (29.90, 551.40) 0.63 (0.16, 3.04)
South Asia 10.58 (2.75, 50.59) 0.02 (0.02, 0.02) 11.73 (3.05, 56.12) 22.49 (5.99, 106.90) 0.84 (0.22, 3.99)
Sub-Saharan Africa 23.56 (6.59, 101.00) 0.02 (0.01, 0.02) 18.31 (5.05, 80.05) 42.06 (11.82, 181.25) 2.58 (0.72, 11.11)
Low and middle income 53.57 (14.41, 244.27) 1.08 (0.90, 1.30) 162.55 (42.62, 769.48) 218.27 (59.01, 1, 016.13) 0.83 (0.22, 3.86)
(1) Default scenario (not in parentheses) based on discount rate on benefits of 3% and long-term GDP growth rate assumption of 3%. Figures in parentheses
are lower and higher bound estimates based on assumptions of 1.5% discount rate on benefits and 5% long-term GDP growth rate for the figure on the left and
5% discount rate on benefits and 1.5% long-term GDP growth rate for the figure on the right.
approach. The economic losses estimated for East Asia and the billion annually or 0.7% of global GNI (Table 4). The total econom-
Pacific, Latin America and the Caribbean, and Sub-Saharan Africa ic losses as a share of GNI are highest in Sub-Saharan Africa at
regions equal US$74.8, US$32.3, US$18.3 billion, respectively 2.58% followed by the Middle East and North Africa and Latin
(Figure 3 and Table 4). Over 56% of the share of the total global America and the Caribbean at 0.91% and 0.84%, respectively
economic losses is projected to be borne by LMICs (Table 4). The (Figure 4). In country income group, the total economic losses as a
combined total economic losses, including health system cost, mor- share of GNI are highest in low-income countries at 1.96% followed
tality losses and cognitive losses were estimated to be US$341.3 by lower middle-income countries at 1.35% of GNI (Table 4). The
414 Health Policy and Planning, 2019, Vol. 34, No. 6
estimates of economic losses for all individual countries with data because of their strategic importance for achieving the Sustainable
available can be found in Supplementary Appendix A6–8. Development Goals.
Sensitivity analysis
China
Estimating the economic losses far into the future comes with sig-
In China, the prevalence of exclusive breastfeeding in children below
nificant uncertainty. In the sensitivity analysis, the total global eco-
the age of 6 months is 21% (UNICEF, 2017). An estimated 16 146
nomic losses decreased to US$91.0 billion or 0.2% of GNI using
child deaths due to preventable diarrhoea and pneumonia were
conservative discounting and growth assumptions and increased to
attributed to not breastfeeding according to recommendations and
US$1.6 trillion or 3.29% of GNI with optimistic assumptions
22 537 deaths in women from cancers and type II diabetes each year
(Table 4). By calculating children’s cognitive losses with the alterna-
(Table 5 and Supplementary Appendix Tables A3 and A4). The esti-
tive approach, which assumes that breastfeeding at 6 months is asso-
mated health system cost of treatment of cases of childhood diar-
ciated with a 2.62 point IQ increase compared with not being
rhoea and pneumonia and mothers’ type II diabetes equals US$196
breastfed with data from 117 countries, the economic losses by per-
million per year (Supplementary Appendix Table A5). The economic
sons who were not breastfeeding according to recommendations
loss of mortality, from the number of preventable deaths, was esti-
were estimated to equal US$210.13 billion annually. The total eco-
mated to cost the Chinese economy approximately $6.3 billion each
nomic losses, which combine the health system costs, economic
year (Supplementary Appendix Table A6). However, with a rapidly
losses from mortality and cognitive losses, are therefore estimated to
declining child mortality rate in China, cognitive losses, estimated to
be US$257.9 billion annually or 0.37% of global GNI. For this al-
be US$59 billion (Supplementary Appendix Table A7), are the main
ternative approach, the total global economic losses decreased to
driver of the total economic losses. Therefore, the total economic
US$69.0 billion or 0.1% of GNI using conservative discounting and
cost of not breastfeeding according to recommendation was esti-
growth assumptions and increased to US$1.2 trillion or 1.75% of
mated to be US$66.1 billion, which translates to 0.61 of China’s
GNI with optimistic assumptions. Therefore, the potential future
GNI (Table 5 and Supplementary Appendix Table A8).
economic losses could vary widely, but regardless the economic con-
sequences in all scenarios remain substantial. The key drivers of
these economic losses estimated were by the number of children not
breastfed according to recommendations, the scale of mortality due India
to sub-optimal breastfeeding, economic growth and discount rates Despite a reported 55% prevalence of exclusive breastfeeding in
selected for the analysis. Sensitivity analysis results for regions and children below the age of 6 months (UNICEF, 2017), there were an
income groups are listed in Table 4 and Supplementary Appendix estimated 99 552 child deaths each year due to diarrhoea and pneu-
Tables A6–8 for individual countries with data. monia that could have been prevented with breastfeeding in India
(Table 5 and Supplementary Appendix Table A3). The key drivers
of this high mortality are India’s large population and high under-
Case study countries: China, India, Indonesia, Mexico five mortality rate. The estimated health system cost of treatment of
and Nigeria cases of childhood diarrhoea and pneumonia and women’s type II
This section highlights the country-level results from the Cost of diabetes equals US$106 million per year (Supplementary Appendix
Not Breastfeeding Tool from five large emerging economies, which Table A5). The high level of child mortality disproportionately
together contain 53% of the population of all developing countries, affects the total economic cost of not breastfeeding in India, which
Health Policy and Planning, 2019, Vol. 34, No. 6 415
Table 5 Total mortality and economic losses due to not breastfeeding for China, India, Indonesia, Mexico and Nigeria
Total child deaths Total maternal deaths Total cost (health, mortality and cognitive) (US$ b) Total cost as % of GNI
was estimated to be US$14.5 billion, or 0.69% of GNI rates and high incomes, which compounded with income growth
(Supplementary Appendix Table A8). into higher economic losses in the future. This analysis showed that
Eickmann SH, De Lira PIC, Lima MC et al. 2007. Breast feeding and mental Anemia, Breastfeeding, and Wasting. Directions in Development–Human
and motor development at 12 months in a low-income population in north- Development. Washington, DC: World Bank Group
east Brazil. Paediatric and Perinatal Epidemiology 21: 129–37. Smith JP, Thompson JF, Ellwood DA. 2002. Hospital system costs of artificial
Hanushek E, Woessmann L. 2008. The role of cognitive skills in economic de- infant feeding: estimates for the Australian Capital Territory. Australian
velopment. Journal of Economic Literature 46: 607–68. and New Zealand Journal of Public Health 26: 543–51.
Holla R, Iellamo A, Gupta A et al. 2015. Investing in breastfeeding–the World UNICEF. 2016a. From the First Hour of Life: Making the Case for Improved
Breastfeeding Costing Initiative. International Breastfeeding Journal 10: Infant and Young Child Feeding Everywhere. New York, NY: UNICEF.
1–12. UNICEF. 2016b. Multiple-Indicator Cluster Survey: Compiler. http://www.
Horta BL, Loret de Mola C, Victora CG. 2015. Breastfeeding and intelligence: micscompiler.org/ [2017, 07/07].
a systematic review and meta-analysis. Acta Paediatrica 104: 14–9. UNICEF. 2017. Infant and Young Child Feeding Database. https://data.uni
Horton S, Sanghvi T, Phillips M et al. 1996. Breastfeeding promotion and pri- cef.org/topic/nutrition/infant-and-young-child-feeding/, accessed 7 July 2017.
ority setting in health. Health Policy and Planning 11: 156–68. United Nations Department of Economic and Social Affairs. 2015. World
Institute for Health Metrics and Evaluation. 2017. Global burden of disease Population Prospects. http://esa.un.org/unpd/wpp/, accessed 1 November 2015.
results tool. http://ghdx.healthdata.org/gbd-results-tool, accessed 7 July 2017. Victora CG, Bahl R, Barros AJ et al. 2016. Breastfeeding in the 21st century:
International Agency for Research on Cancer. 2012. Estimated Cancer epidemiology, mechanisms, and lifelong effect. Lancet (London, England)
Incidence, Prevalence and Mortality Worldwide in 2012. http://globocan. 387: 475–90.